Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitors by Liang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, Chang-Ting Lin, Hao-Lun Luo, Chih-Chi Chou, Shih-Yu Huang, Chia-Che Wu, Chien-Hsu Chen, Chun-Chieh Huang, Kai-Lung Tsai, Harvey Yu-Li Su

Get full text